CLINICAL TRIALS PROFILE FOR MAGNEVIST
✉ Email this page to a colleague
All Clinical Trials for MAGNEVIST
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00185276 ↗ | Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries | Completed | Bayer | Phase 3 | 2003-03-01 | The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the infrarenal aorta and peripheral arteries. The results will be compared to the results of MRI taken without Magnevist, and with the results of your X-ray angiography. |
| NCT00309075 ↗ | Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries | Completed | Bayer | Phase 3 | 2003-12-01 | The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the calf and foot arteries. The results will be compared to the results of MRI taken without Magnevist, and with the results of your X-ray angiography. |
| NCT00310544 ↗ | Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction | Completed | Bayer | Phase 2 | 2006-03-01 | The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle. |
| NCT00310557 ↗ | Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries | Completed | Bayer | Phase 3 | 2003-12-01 | The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the renal arteries. The results will be compared to the results of MRI taken without Magnevist and with the results of your X-ray angiography. |
| NCT00310596 ↗ | Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects | Completed | Bayer | Phase 1 | 2004-01-01 | The purpose of this study is to determine what effect Magnevist (gadopentetate dimeglumine) injection has on the way the heart conducts the electrical impulses that allow it to beat effectively. The study will compare Magnevist injection's effect to that of placebo (a saline injection). |
| NCT00310609 ↗ | Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches | Completed | Bayer | Phase 3 | 2003-12-01 | The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the aortic arch and cerebral branches. The results will be compared to the results of MRI taken without Magnevist, and with the results of your X-ray angiography. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MAGNEVIST
Condition Name
Clinical Trial Locations for MAGNEVIST
Trials by Country
Clinical Trial Progress for MAGNEVIST
Clinical Trial Phase
Clinical Trial Sponsors for MAGNEVIST
Sponsor Name
